Study of Huaier Granules to Prevent Recurrence and Spread of Colorectal Cancer After Radical Surgery in Adults Aged 18 to 75

What this Trial Is About

Researchers are evaluating Huaier granules to prevent the return and spread of colorectal cancer in patients who have undergone radical surgery. This open-label, real-world study aims to assess both the effectiveness and safety of Huaier granules in this patient group. The study is conducted at multiple sites and sponsored by Xi Shan Wang. Participants will be observed in one of three groups those receiving radiotherapy or chemotherapy alone, those receiving Huaier granules combined with radiotherapy or chemotherapy, and those receiving Huaier granules alone. The study follows patients after their surgery to monitor how these different approaches impact cancer recurrence and metastasis. During the 36-month study period, participants will undergo regular assessments to measure disease-free survival, overall survival, local recurrence-free survival, and distant metastasis-free survival. Researchers will also collect data on quality of life changes, adverse events, and immune function. Participants will be monitored closely to track their health and treatment effects throughout the study duration.

Huaier Granules for Prevention of Recurrence and Metastasis of Colorectal Cancer Patients Following Radical Surgery